Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 19, Issue 8, Pages 715-721
Publisher
Informa UK Limited
Online
2018-05-01
DOI
10.1080/15384047.2018.1451279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress
- (2016) W. Rozpedek et al. CURRENT MOLECULAR MEDICINE
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells
- (2015) MARIKO SATO et al. Molecular Medicine Reports
- Cbx4 Governs HIF-1α to Potentiate Angiogenesis of Hepatocellular Carcinoma by Its SUMO E3 Ligase Activity
- (2014) Jie Li et al. CANCER CELL
- How Thalidomide Works Against Cancer
- (2014) A. K. Stewart SCIENCE
- Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway
- (2014) Jee-Young Park et al. CELLULAR ONCOLOGY
- The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients
- (2014) Pawel Sadlecki et al. Biomed Research International
- Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation
- (2013) Maimon E. Hubbi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells
- (2013) Elena Miranda et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- CysLT1R Antagonists Inhibit Tumor Growth in a Xenograft Model of Colon Cancer
- (2013) Sayeh Savari et al. PLoS One
- Structure–activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent
- (2012) Jiyoung Mun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Metformin intake is associated with better survival in ovarian cancer
- (2012) Sanjeev Kumar et al. CANCER
- SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
- (2012) Marco Montagner et al. NATURE
- Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells
- (2011) S M Manohar et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
- (2009) Nahum Sonenberg et al. CELL
- Role of hypoxia in the hallmarks of human cancer
- (2009) Kai Ruan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search